Saladax Biomedical Inc. Strengthens Team with New Director
Saladax Biomedical, Inc., renowned for its innovative therapeutic drug monitoring solutions, is excited to introduce Ms. Stacie Geffner-Atiya as the new Director of Regulatory and Quality. With an impressive background accumulating over 20 years in regulatory affairs for in vitro diagnostics and medical devices, she brings substantial experience in navigating the complex landscape of global regulations.
Bringing Expertise and Strategic Leadership
Ms. Geffner-Atiya has a remarkable track record of success in guiding regulatory strategies at both large established corporations and emerging start-ups. She has been instrumental in obtaining various regulatory clearances, including IVDRR, 510(k) submissions, and PMAs. Her diverse experience encompasses a wide range of medical products such as point-of-care glucose meters, endoscopes, infusion pumps, and insulin pumps.
CEO’s Enthusiastic Support
"We are thrilled to welcome Ms. Geffner-Atiya to the Saladax team," commented Sal Salamone, the CEO of Saladax Biomedical, Inc. He expressed confidence that her extensive regulatory expertise and strategic vision will play a pivotal role in advancing Saladax's mission of providing rapid and precise therapeutic drug monitoring assays. "Her proven ability to secure regulatory approvals will ensure that our innovative solutions successfully reach patients and healthcare providers around the globe," he added.
Education and Responsibilities
Ms. Geffner-Atiya holds a Bachelor of Science degree from the State University of New York at Brockport. In her new capacity at Saladax, she will oversee various critical functions, including regulatory compliance, quality assurance, and global submission strategies. This leadership role is designed to reinforce Saladax's commitment to delivering high-quality and reliable diagnostic solutions.
About Saladax Biomedical, Inc.
With headquarters in Bethlehem, PA, Saladax Biomedical, Inc., is a dynamic company focused on the development, manufacturing, and marketing of assays that deliver rapid therapeutic drug level assessments. These are crucial for essential and life-saving medications often prescribed by psychiatrists and oncologists. Since its inception in 2007, Saladax's proprietary technology has significantly contributed to clinical laboratories and point-of-care settings, assisting healthcare professionals in optimizing patient care.
Moreover, the company collaborates extensively with leading pharmaceutical firms to create tests for clinical trials and companion diagnostics, aiming to enhance medical outcomes.
For additional details, visit MyCareTests.com.
Contact Information
For inquiries, you can reach out to:
Elizabeth Reidenbach SWBR 7173682025 elizabeth.reidenbach@swbrinc.com
Frequently Asked Questions
What is the role of Stacie Geffner-Atiya at Saladax Biomedical?
Stacie Geffner-Atiya serves as the Director of Regulatory and Quality, overseeing compliance and submission strategies.
What experience does Ms. Geffner-Atiya bring to her new role?
She brings over 20 years of regulatory experience in diagnostic and medical device sectors, including significant roles at large corporations and start-ups.
What is the primary focus of Saladax Biomedical?
Saladax Biomedical focuses on developing and marketing innovative therapeutic drug monitoring assays for crucial medications.
How does Saladax Biomedical support healthcare providers?
Saladax provides rapid testing solutions that help healthcare providers in monitoring and optimizing patient care.
Where is Saladax Biomedical headquartered?
The company is based in Bethlehem, PA.
